Hypertension Clinical Trial
To examine in postmenopausal women the potential interactions of hormone replacement therapy with other blood clotting factors on the risk of cardiovascular diseases such as heart attack or stroke.
BACKGROUND:
Estrogens are prothrombotic. Recently, the Heart and Estrogen/progestin Replacement Study
(HERS), renewed interest in the adverse effects of hormone replacement therapy (HRT). In
HERS, HRT was no better than placebo at preventing coronary events. In post hoc analyses,
treatment was associated with early harm and late benefit. In an American Heart Association
funded case-control study, a potential interaction was observed between HRT and the
prothrombin G20210A variant on the risk of first myocardial infarction (MI) in
post-menopausal women with hypertension.
DESIGN NARRATIVE:
The study has a case-control design. The Group Health Cooperative (GHC) computerized files
will be used to identify postmenopausal women, aged 30 to 79 yrs, with incident myocardial
infarction (MI) or stroke during 1/2000-12/2004. Population-based controls, sampled from the
GHC enrollment files, will be frequency matched to cases by age, calendar year, and treated
hypertension. Data collection will include medical-record review, telephone interview of
consenting subjects, and venous-blood collection. Standard methods will be used to assay
variant alleles. The GHC computerized pharmacy records will serve as the primary source of
information about the use of HRT. Data analysis will involve restriction, stratification, and
logistic regression. Case-control and case-only analyses are planned. There will be a total
of 600 MI cases, 420 stroke cases and 1800 controls.
The primary purpose is to examine the potential interactions of hormone replacement therapy
with other procoagulant variants on the risk of cardiovascular events. The main variants of
interest are: (la) factor XIIIA Val34Leu; (ib) platelet glycoprotein (PGP) Jib Ile843Ser;
(ic) PGP IIIa Leu33Pro; and (id) PGP Ia C807T. The secondary aims include the assessment of
other drug-gene, risk-factor-gene or gene-gene interactions on risk: (2a) the interaction
between PGP IIb Ser843, PGP lila Leu33Pro and PGP Ia C807T and traditional cardiovascular
risk factors such as smoking and obesity on the risk of MI and stroke; (2b) the interaction
between three coagulation factor XIII polymorphisms and PAl-1 4G/5G on the risk of stroke in
women; and (2c) the interaction between aspirin use and glycoprotein IIIa Leu33Pro on the
risk of MI and stroke.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |